From the laboratory to the clinician to the patient, discover how we’re powering the moments that matter.
Did you know Beckman Coulter is a part of Danaher's diagnostics companies?
Together with Danaher's diagnostics businesses, we are accelerating the real-life impact of precision diagnostics, enabling healthcare providers to diagnose diseases with unprecedented speed and precision.
Across our industry-leading operating companies and through academic and research partnerships, we’re bringing the best minds together to unlock the full potential of the latest scientific advances—accelerating innovation that will ensure precision medicine for future generations of patients.
You already know our industry-leading diagnostics businesses. Get to know Danaher.
Book appointment ›
Through expertise and strategic partnerships, we are pushing boundaries with next-generation technologies that improve workflow and drive confidence in patient results. From innovative biomarkers to workflow automation, here are just a few of the solutions that will be on display at ADLM.
Advantaged Workflow
Accelerate more precise clinical decision-making—from sample collection to diagnostic insight—unlocking the power of every sample and improving workflow to create new value for your laboratory teams.
Learn more
Digital Hematology
Discover how we’re delivering more insights from the CBC so you can support a higher standard of care with a growing menu of advanced biomarkers and unparalleled clinical sensitivity.
Learn more
High-Sensitivity Diagnostics
Revolutionize your core lab’s impact with unprecedented high-sensitivity diagnostic testing across diverse areas like cardiovascular disease, infectious disease, and women’s health.
Learn more
We’ve got a lot to share in Chicago—and we don’t want you to miss a single insight. See our schedule below for in-booth presentations
from Beckman Coulter, Cepheid, Radiometer, and Leica.
More info coming soon!
Date: Wednesday, July 30
Time: 7:00 – 8:30am
Leaders from three academic medical centers will share real-world implementation experiences of the same diagnostic test - the MeMed BV Assay - each tailored to their institution’s unique clinical and operational priorities. Johns Hopkins Medical Center will highlight strategies for driving physician acceptance and evaluating clinical performance. Maimonides Medical Center will discuss its focus on diagnostic stewardship and improving physician adherence. Texas Children's Hospital will share its approach to advancing antibiotic stewardship in the care of complex pediatric patients.
Attendees will gain practical insights into how different healthcare settings align diagnostic implementation with institutional goals—providing actionable strategies to support successful adoption and measurable impact.
Catch up with these educational resources shared at ADLM 2024.
Tell us you're coming and we'll connect you with a member of the Beckman Coulter team for a tailored demo of the solutions that matter to you.
Complete the form below and we’ll reach out soon.
Thank you for your request.
A Beckman Coulter representative will contact you shortly.
English
